LCA168 FOR GLIOBLASTOMA?

Glioblastoma is a formidable brain malignancy known for its quick growth and insensitivity to standard treatments. Studies are constantly underway to identify new management strategies, and recently, a novel biomarker named LCA168 has emerged as a potential focus for GBM treatment. LCA168 is a protein that is overexpressed in GBM cells compared to